Albers Jeffrey W.
Insider CIK 1638474 · BPMC CEO and President, Director · SYRE Director · MGTA Director · KYMR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-08-07 | 2026-08-10 | 5,000 | — | $0 | 45,000 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 10,000 | $104.68 | $1.05M | 9,360 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 8,000 | $104.38 | $835.0K | 19,360 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 5,000 | $104.47 | $522.4K | 0 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-08-07 | 2026-08-10 | 5,000 | $10.39 | $52.0K | 5,000 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise deriv | 2026-08-07 | 2026-08-10 | 5,000 | — | $0 | 45,000 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 10,000 | $104.68 | $1.05M | 9,360 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 8,000 | $104.38 | $835.0K | 19,360 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 5,000 | $104.47 | $522.4K | 0 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | M Exercise | 2026-08-07 | 2026-08-10 | 5,000 | $10.39 | $52.0K | 5,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 6,068 | — | $0 | 6,068 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2026-05-27 | 2026-05-29 | 8,026 | — | $0 | 8,026 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-12-08 | 2025-12-08 | 5,000 | — | $0 | 7,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-12-08 | 2025-12-08 | 5,000 | $14.18 | $70.9K | 5,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 2,748 | $89.32 | $245.5K | 2,252 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 2,252 | $90.30 | $203.4K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-10-13 | 2025-10-14 | 5,000 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-13 | 2025-10-14 | 5,000 | $59.19 | $295.9K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-10-13 | 2025-10-14 | 5,000 | $10.34 | $51.7K | 5,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 90,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 15,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 80,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 110,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 170,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 92,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 5,777 | — | $0 | 144,755 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 144,755 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 150,532 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-03 | 6,349 | — | $0 | 5,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-06-03 | 2025-06-03 | 6,349 | $10.34 | $65.6K | 6,349 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-06-03 | 2025-06-03 | 6,349 | $49.00 | $311.1K | 0 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2025-05-27 | 2025-05-29 | 5,000 | — | $0 | 92,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2025-05-27 | 2025-05-29 | 5,000 | $36.05 | $180.3K | 151,630 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-27 | 2025-05-29 | 650 | $101.93 | $66.3K | 146,630 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-05-27 | 2025-05-29 | 4,350 | $101.02 | $439.4K | 147,280 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2025-03-12 | 2025-03-14 | 7,500 | — | $0 | 97,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-12 | 2025-03-14 | 1,800 | $88.37 | $159.1K | 152,396 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2025-03-12 | 2025-03-14 | 7,500 | $36.05 | $270.4K | 159,896 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-12 | 2025-03-14 | 5,700 | $87.62 | $499.4K | 154,196 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-05 | 2025-03-17 | 5,766 | $88.80 | $512.0K | 146,630 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2025-01-21 | 2025-01-23 | 10,000 | — | $0 | 105,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-21 | 2025-01-23 | 200 | $110.61 | $22.1K | 152,396 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-21 | 2025-01-23 | 7,400 | $109.92 | $813.4K | 152,596 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-21 | 2025-01-23 | 7,561 | $109.11 | $825.0K | 159,996 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2025-01-21 | 2025-01-23 | 10,000 | $36.05 | $360.5K | 167,557 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2025-01-13 | 2025-01-15 | 5,000 | — | $0 | 115,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2025-01-13 | 2025-01-15 | 5,000 | $36.05 | $180.3K | 162,557 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-01-13 | 2025-01-15 | 5,000 | $102.28 | $511.4K | 157,557 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-12-19 | 2024-12-20 | 15,000 | $36.05 | $540.8K | 120,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-12-19 | 2024-12-20 | 15,000 | $36.05 | $540.8K | 172,557 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-12-19 | 2024-12-20 | 3,920 | $88.28 | $346.1K | 168,637 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-12-19 | 2024-12-20 | 5,180 | $89.01 | $461.1K | 163,457 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-12-19 | 2024-12-20 | 3,800 | $91.15 | $346.4K | 159,657 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-12-19 | 2024-12-20 | 2,100 | $91.96 | $193.1K | 157,557 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-11-07 | 2024-11-12 | 5,000 | — | $0 | 135,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-11-07 | 2024-11-12 | 5,000 | $36.05 | $180.3K | 162,557 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-11-07 | 2024-11-12 | 5,000 | $102.00 | $510.0K | 157,557 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 6,700 | $36.76 | $246.3K | 27,360 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | S Sale | 2024-10-25 | 2024-10-28 | 300 | $36.43 | $10.9K | 34,060 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-09-09 | 2024-09-11 | 10,000 | — | $0 | 140,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-09-09 | 2024-09-11 | 10,000 | $36.05 | $360.5K | 177,259 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-09-09 | 2024-09-11 | 11,968 | $85.86 | $1.03M | 165,291 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-09-09 | 2024-09-11 | 7,734 | $85.12 | $658.3K | 157,557 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-08-26 | 2024-08-26 | 5,000 | — | $0 | 11,349 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-08-26 | 2024-08-26 | 5,000 | $10.34 | $51.7K | 5,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-08-26 | 2024-08-26 | 5,000 | $49.10 | $245.5K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 16,000 | — | $0 | 16,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-06-12 | 2024-06-14 | 4,570 | — | $0 | 4,570 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-06-12 | 2024-06-14 | 2,242 | — | $0 | 167,259 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2024-05-14 | 2024-05-16 | 11,323 | — | $0 | 11,323 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-03-20 | 2024-03-22 | 10,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-03-20 | 2024-03-22 | 15,073 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-03-20 | 2024-03-22 | 10,000 | $15.01 | $150.1K | 201,123 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-03-20 | 2024-03-22 | 15,073 | $1.87 | $28.2K | 191,123 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-20 | 2024-03-22 | 1,367 | $89.12 | $121.8K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-20 | 2024-03-22 | 6,285 | $88.60 | $556.9K | 177,417 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-20 | 2024-03-22 | 8,440 | $87.26 | $736.5K | 183,702 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-20 | 2024-03-22 | 6,251 | $86.46 | $540.5K | 192,142 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-20 | 2024-03-22 | 2,730 | $85.22 | $232.7K | 198,393 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-07 | 2024-03-26 | 11,033 | $90.69 | $1.00M | 165,017 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-02-21 | 2024-02-21 | 4,385 | — | $0 | 16,349 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-02-21 | 2024-02-21 | 4,385 | $39.05 | $171.2K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-02-21 | 2024-02-21 | 4,385 | $10.34 | $45.3K | 4,385 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-02-20 | 2024-02-21 | 615 | — | $0 | 20,734 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-02-20 | 2024-02-21 | 615 | $10.34 | $6.4K | 615 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-02-20 | 2024-02-21 | 615 | $39.07 | $24.0K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-01-25 | 2024-01-29 | 15,000 | — | $0 | 15,073 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-01-25 | 2024-01-29 | 10,000 | — | $0 | 2,496 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-01-25 | 2024-01-29 | 10,000 | $15.01 | $150.1K | 201,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-01-25 | 2024-01-29 | 6,086 | $81.16 | $493.9K | 194,964 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-01-25 | 2024-01-29 | 10,890 | $81.70 | $889.7K | 184,074 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-01-25 | 2024-01-29 | 7,924 | $82.76 | $655.8K | 176,150 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-01-25 | 2024-01-29 | 100 | $83.57 | $8.4K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-01-25 | 2024-01-29 | 15,000 | $1.87 | $28.1K | 191,050 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-01-23 | 2024-01-23 | 10,000 | — | $0 | 21,349 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-01-23 | 2024-01-23 | 10,000 | $10.34 | $103.4K | 10,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-01-23 | 2024-01-23 | 10,000 | $30.05 | $300.5K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-12-11 | 2023-12-13 | 5,000 | — | $0 | 150,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-12-11 | 2023-12-13 | 5,000 | $36.05 | $180.3K | 181,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-12-11 | 2023-12-13 | 5,000 | $79.07 | $395.3K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-11-30 | 2023-12-04 | 5,000 | — | $0 | 155,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-11-30 | 2023-12-04 | 5,000 | $36.05 | $180.3K | 181,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-11-30 | 2023-12-04 | 5,000 | $70.55 | $352.8K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-11-24 | 2023-11-28 | 15,000 | — | $0 | 30,073 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | C Conversion deriv | 2023-11-24 | 2023-12-08 | 859 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-11-24 | 2023-11-28 | 15,000 | $1.87 | $28.1K | 191,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-11-24 | 2023-11-28 | 7,036 | $67.81 | $477.1K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-11-24 | 2023-11-28 | 7,964 | $67.25 | $535.6K | 183,086 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | C Conversion | 2023-11-24 | 2023-12-08 | 34,360 | — | $0 | 34,360 | SEC↗ |
| AGLE Spyre Therapeutics, Inc. | A Award deriv | 2023-11-22 | 2023-11-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SYRE Spyre Therapeutics, Inc. | A Award deriv | 2023-11-22 | 2023-12-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-11-03 | 2023-11-03 | 1,485 | — | $0 | 160,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-11-03 | 2023-11-03 | 1,485 | $36.05 | $53.5K | 177,535 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-11-03 | 2023-11-03 | 1,485 | $60.13 | $89.3K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-11-02 | 2023-11-03 | 4,634 | — | $0 | 161,485 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-11-02 | 2023-11-03 | 4,634 | $36.05 | $167.1K | 180,684 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-11-02 | 2023-11-03 | 4,575 | $60.36 | $276.1K | 176,109 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-11-02 | 2023-11-03 | 59 | $61.05 | $3.6K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-11-01 | 2023-11-03 | 3,881 | — | $0 | 166,119 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-11-01 | 2023-11-03 | 3,881 | $60.02 | $232.9K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-11-01 | 2023-11-03 | 3,881 | $36.05 | $139.9K | 179,931 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-09-28 | 2023-09-29 | 6,898 | — | $0 | 45,073 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-09-28 | 2023-09-29 | 6,898 | $1.87 | $12.9K | 182,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-09-28 | 2023-09-29 | 6,898 | $50.17 | $346.1K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-09-27 | 2023-09-29 | 18,102 | — | $0 | 51,971 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-09-27 | 2023-09-29 | 18,102 | $1.87 | $33.9K | 194,152 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-09-27 | 2023-09-29 | 5,600 | $48.84 | $273.5K | 188,552 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-09-27 | 2023-09-29 | 12,102 | $49.93 | $604.3K | 176,450 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-09-27 | 2023-09-29 | 400 | $50.50 | $20.2K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-08-25 | 2023-08-28 | 10,000 | — | $0 | 70,073 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-08-25 | 2023-08-28 | 10,000 | $50.16 | $501.6K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-08-25 | 2023-08-28 | 10,000 | $1.87 | $18.7K | 186,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-08-24 | 2023-08-28 | 15,000 | — | $0 | 80,073 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-08-24 | 2023-08-28 | 15,000 | $49.57 | $743.5K | 176,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-08-24 | 2023-08-28 | 15,000 | $1.87 | $28.1K | 191,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-06-21 | 2023-06-23 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-06-21 | 2023-06-23 | 2,600 | — | $0 | 176,050 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 319 | $44.27 | $14.1K | 173,450 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 9,474 | $45.72 | $433.2K | 173,769 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-12-05 | 2022-12-07 | 10,000 | — | $0 | 20,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-12-05 | 2022-12-07 | 10,000 | — | $0 | 95,073 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-12-05 | 2022-12-07 | 10,000 | $15.01 | $150.1K | 203,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-12-05 | 2022-12-07 | 20,000 | $50.09 | $1.00M | 183,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-12-05 | 2022-12-07 | 10,000 | $1.87 | $18.7K | 193,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-08-22 | 2022-08-23 | 8,410 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-08-22 | 2022-08-23 | 8,410 | $15.01 | $126.2K | 191,653 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-08-22 | 2022-08-23 | 7,748 | $70.47 | $546.0K | 183,905 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-08-22 | 2022-08-23 | 662 | $71.30 | $47.2K | 183,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-08-19 | 2022-08-23 | 1,590 | — | $0 | 38,410 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-08-19 | 2022-08-23 | 1,590 | $70.02 | $111.3K | 183,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-08-19 | 2022-08-23 | 1,590 | $15.01 | $23.9K | 184,833 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-08-16 | 2022-08-18 | 10,000 | — | $0 | 40,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-08-16 | 2022-08-18 | 10,000 | — | $0 | 105,073 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-08-16 | 2022-08-18 | 293 | $69.52 | $20.4K | 183,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-08-16 | 2022-08-18 | 12,477 | $68.62 | $856.2K | 183,536 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-08-16 | 2022-08-18 | 7,230 | $68.01 | $491.7K | 196,013 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-08-16 | 2022-08-18 | 10,000 | $15.01 | $150.1K | 203,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-08-16 | 2022-08-18 | 10,000 | $1.87 | $18.7K | 193,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-08-08 | 2022-08-10 | 7,170 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-08-08 | 2022-08-10 | 2,830 | — | $0 | 115,073 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-08-08 | 2022-08-10 | 2,830 | $1.87 | $5.3K | 193,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-08-08 | 2022-08-10 | 10,000 | $70.07 | $700.7K | 183,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-08-08 | 2022-08-10 | 7,170 | $8.80 | $63.1K | 190,413 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2022-06-28 | 2022-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-05-16 | 2022-05-18 | 10,000 | — | $0 | 117,903 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-05-16 | 2022-05-18 | 10,000 | — | $0 | 50,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-05-16 | 2022-05-18 | 10,000 | $15.01 | $150.1K | 203,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-05-16 | 2022-05-18 | 12,758 | $56.21 | $717.1K | 183,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-05-16 | 2022-05-18 | 5,342 | $55.63 | $297.2K | 196,001 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-05-16 | 2022-05-18 | 10,000 | $1.87 | $18.7K | 193,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-05-16 | 2022-05-18 | 1,900 | $54.48 | $103.5K | 201,343 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-04-06 | 2022-04-08 | 5,000 | — | $0 | 60,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-04-06 | 2022-04-08 | 5,000 | $70.11 | $350.6K | 183,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-04-06 | 2022-04-08 | 5,000 | $15.01 | $75.0K | 188,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-07 | 2022-03-08 | 4,843 | $56.19 | $272.1K | 183,243 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-03-04 | 2022-03-08 | 12,500 | — | $0 | 65,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2022-03-04 | 2022-03-08 | 7,500 | — | $0 | 127,903 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-04 | 2022-03-08 | 4,445 | $57.66 | $256.3K | 193,586 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-04 | 2022-03-08 | 4,100 | $58.28 | $238.9K | 189,486 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-04 | 2022-03-08 | 10,055 | $56.61 | $569.2K | 198,031 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-04 | 2022-03-08 | 1,400 | $59.43 | $83.2K | 188,086 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-03-04 | 2022-03-08 | 7,500 | $1.87 | $14.0K | 195,586 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2022-03-04 | 2022-03-08 | 12,500 | $15.01 | $187.6K | 208,086 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-03 | 2022-03-08 | 7,862 | $60.28 | $473.9K | 188,086 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-03-01 | 2022-03-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-03-01 | 2022-03-03 | 7,500 | — | $0 | 195,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-11-15 | 2021-11-17 | 22,500 | — | $0 | 77,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-11-15 | 2021-11-17 | 7,500 | — | $0 | 135,403 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-11-15 | 2021-11-17 | 100 | $112.14 | $11.2K | 188,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-11-15 | 2021-11-17 | 22,500 | $15.01 | $337.7K | 218,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-11-15 | 2021-11-17 | 21,906 | $114.73 | $2.51M | 196,542 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-11-15 | 2021-11-17 | 7,894 | $113.92 | $899.3K | 188,648 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-11-15 | 2021-11-17 | 100 | $113.25 | $11.3K | 188,548 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-11-15 | 2021-11-17 | 7,500 | $1.87 | $14.0K | 195,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-11-01 | 2021-11-03 | 5,000 | — | $0 | 100,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-11-01 | 2021-11-03 | 5,000 | $115.16 | $575.8K | 188,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-11-01 | 2021-11-03 | 5,000 | $15.01 | $75.0K | 193,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-08-26 | 2021-08-30 | 16,000 | — | $0 | 142,903 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-08-26 | 2021-08-30 | 16,000 | $1.87 | $29.9K | 188,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-08-19 | 2021-08-23 | 7,500 | — | $0 | 158,903 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-08-19 | 2021-08-23 | 17,500 | — | $0 | 105,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-08-19 | 2021-08-23 | 14,815 | $93.01 | $1.38M | 182,633 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-08-19 | 2021-08-23 | 7,500 | $1.87 | $14.0K | 179,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-08-19 | 2021-08-23 | 17,500 | $15.01 | $262.7K | 197,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-08-19 | 2021-08-23 | 10,185 | $92.21 | $939.2K | 172,448 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,063 | — | $0 | 20,063 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-05-12 | 2021-05-14 | 17,500 | — | $0 | 122,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-05-12 | 2021-05-14 | 7,500 | — | $0 | 166,403 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-05-12 | 2021-05-14 | 2,953 | $91.89 | $271.4K | 172,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-05-12 | 2021-05-14 | 7,500 | $1.87 | $14.0K | 179,948 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-05-12 | 2021-05-14 | 17,500 | $15.01 | $262.7K | 197,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-05-12 | 2021-05-14 | 16,383 | $92.62 | $1.52M | 175,401 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-05-12 | 2021-05-14 | 5,664 | $93.33 | $528.6K | 191,784 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-03-04 | 2021-03-05 | 10,000 | — | $0 | 7,170 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 5,296 | $91.78 | $486.1K | 185,038 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-03-04 | 2021-03-05 | 10,000 | $8.80 | $88.0K | 191,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 1,100 | $93.21 | $102.5K | 190,334 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 8,417 | $86.61 | $729.0K | 172,448 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 3,000 | $90.99 | $273.0K | 182,038 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 569 | $88.63 | $50.4K | 180,865 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 100 | $86.61 | $8.7K | 181,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 100 | $89.18 | $8.9K | 181,534 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 404 | $90.18 | $36.4K | 181,634 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-03-01 | 2021-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-03-01 | 2021-03-03 | 40,000 | — | $0 | 181,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-12-14 | 2020-12-16 | 5,000 | — | $0 | 17,170 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-12-14 | 2020-12-16 | 5,000 | $119.18 | $595.9K | 141,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-12-14 | 2020-12-16 | 5,000 | $8.80 | $44.0K | 146,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-11-16 | 2020-11-18 | 20,000 | — | $0 | 22,170 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-16 | 2020-11-18 | 4,869 | $99.55 | $484.7K | 152,438 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-16 | 2020-11-18 | 4,127 | $100.11 | $413.2K | 157,307 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-16 | 2020-11-18 | 4,483 | $98.13 | $439.9K | 147,955 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-16 | 2020-11-18 | 6,521 | $97.61 | $636.5K | 141,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-11-16 | 2020-11-18 | 20,000 | $8.80 | $176.0K | 161,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-10-07 | 2020-10-09 | 5,000 | — | $0 | 42,170 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-07 | 2020-10-09 | 5,000 | $99.17 | $495.9K | 141,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-10-07 | 2020-10-09 | 5,000 | $8.80 | $44.0K | 146,434 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2020-08-20 | 2020-08-21 | 40,127 | — | $0 | 40,127 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-08-19 | 2020-08-21 | 20,000 | — | $0 | 47,170 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-08-19 | 2020-08-21 | 8,597 | $74.60 | $641.3K | 141,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-08-19 | 2020-08-21 | 11,403 | $75.34 | $859.1K | 150,031 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-08-19 | 2020-08-21 | 20,000 | $8.80 | $176.0K | 161,434 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-05-12 | 2020-05-14 | 20,000 | — | $0 | 67,170 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-05-12 | 2020-05-14 | 4,282 | $64.75 | $277.3K | 151,002 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-05-12 | 2020-05-14 | 20,000 | $8.80 | $176.0K | 161,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-05-12 | 2020-05-14 | 9,568 | $63.93 | $611.7K | 141,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-05-12 | 2020-05-14 | 6,150 | $65.77 | $404.5K | 155,284 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-03-23 | 2020-03-25 | 20,000 | — | $0 | 173,903 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-03-23 | 2020-03-25 | 19,920 | — | $0 | 87,170 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-03-23 | 2020-03-25 | 80 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-03-23 | 2020-03-25 | 19,920 | $8.80 | $175.3K | 161,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-03-23 | 2020-03-25 | 20,000 | $1.87 | $37.4K | 141,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-03-23 | 2020-03-25 | 80 | $1.87 | $150 | 141,514 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-23 | 2020-03-25 | 3,337 | $50.40 | $168.2K | 141,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-23 | 2020-03-25 | 484 | $55.34 | $26.8K | 160,950 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-23 | 2020-03-25 | 8,850 | $51.30 | $454.0K | 144,771 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-23 | 2020-03-25 | 2,100 | $52.11 | $109.4K | 153,621 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-23 | 2020-03-25 | 1,936 | $53.54 | $103.7K | 155,721 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-23 | 2020-03-25 | 3,293 | $54.62 | $179.9K | 157,657 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-09 | 2020-03-11 | 2,277 | $51.97 | $118.3K | 121,434 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-03-01 | 2020-03-03 | 90,000 | — | $0 | 90,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-03-01 | 2020-03-03 | 45,000 | — | $0 | 123,711 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-11-18 | 2019-11-20 | 2,000 | — | $0 | 107,090 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-11-18 | 2019-11-20 | 18,000 | — | $0 | 80 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-11-18 | 2019-11-20 | 2,000 | $8.80 | $17.6K | 68,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-11-18 | 2019-11-20 | 600 | $76.16 | $45.7K | 68,361 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-11-18 | 2019-11-20 | 7,656 | $75.36 | $577.0K | 60,705 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-11-18 | 2019-11-20 | 18,000 | $1.87 | $33.7K | 66,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-11-08 | 2019-11-20 | 11,744 | $74.56 | $875.6K | 48,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-10-30 | 2019-10-30 | 20,000 | — | $0 | 193,903 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-10-30 | 2019-10-30 | 20,000 | $1.87 | $37.4K | 48,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-08-19 | 2019-08-21 | 20,000 | — | $0 | 18,080 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-19 | 2019-08-21 | 300 | $82.85 | $24.9K | 47,761 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-19 | 2019-08-21 | 800 | $84.42 | $67.5K | 48,061 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-19 | 2019-08-21 | 6,634 | $82.04 | $544.3K | 41,127 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-19 | 2019-08-21 | 12,166 | $81.33 | $989.5K | 28,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-08-19 | 2019-08-21 | 100 | $85.56 | $8.6K | 48,861 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-08-19 | 2019-08-21 | 20,000 | $1.87 | $37.4K | 48,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-06-17 | 2019-06-19 | 5,000 | — | $0 | 38,080 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-17 | 2019-06-19 | 5,000 | $99.06 | $495.3K | 28,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-06-17 | 2019-06-19 | 5,000 | $1.87 | $9.3K | 33,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-06-12 | 2019-06-14 | 20,000 | — | $0 | 43,080 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 9,191 | $85.72 | $787.9K | 39,770 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 4,859 | $84.61 | $411.1K | 34,911 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 4,050 | $83.81 | $339.4K | 30,861 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-12 | 2019-06-14 | 1,900 | $82.37 | $156.5K | 28,961 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-06-12 | 2019-06-14 | 20,000 | $1.87 | $37.4K | 48,961 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-03-15 | 2019-03-19 | 20,000 | — | $0 | 63,080 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-03-15 | 2019-03-19 | 4,451 | $87.44 | $389.2K | 44,510 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-03-15 | 2019-03-19 | 9,423 | $86.41 | $814.2K | 35,087 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-03-15 | 2019-03-19 | 6,126 | $85.61 | $524.4K | 28,961 | SEC↗ |